Skip to main content
Premium Trial:

Request an Annual Quote

Rules Based Medicine to Pay Luminex $12.5M to Settle Lawsuit

NEW YORK (GenomeWeb News) — Rules Based Medicine will pay Luminex $12.5 million to settle a law suit having to do with Biophysical Corporation’s testing services, Luminex said today.
 
RBM, which was spun off from Luminex in September 2002, initially filed the claims in a Travis County, Texas District Court in 2005, but Luminex soon afterward responded with its own counterclaims.
  
The settlement, which formally dismisses the lawsuit, includes the retirement of Luminex’s ownership of RBM stock and “the grant of certain additional licensing rights,” Luminex said.
 
All other terms of the agreement are confidential, Luminex said.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.